VERU INC (VERU)
US92536C1036 - Common Stock
VERU gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 37 industry peers in the Personal Care Products industry. While VERU seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, VERU is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
VERU had negative earnings in the past year.
VERU had a negative operating cash flow in the past year.
In the past 5 years VERU reported 4 times negative net income.
VERU had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -49.89%, VERU is not doing good in the industry: 81.08% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -79.23%, VERU is doing worse than 70.27% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -49.89% | ||
| ROE | -79.23% | ||
| ROIC | N/A |
ROA(3y)-81.21%
ROA(5y)-60.58%
ROE(3y)-190.74%
ROE(5y)-134.49%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 34.13%, VERU is not doing good in the industry: 75.68% of the companies in the same industry are doing better.
VERU's Gross Margin has declined in the last couple of years.
VERU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 34.13% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.73%
GM growth 5Y-3.46%
2. Health
2.1 Basic Checks
VERU does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VERU has more shares outstanding
VERU has more shares outstanding than it did 5 years ago.
VERU has a worse debt/assets ratio than last year.
2.2 Solvency
VERU has an Altman-Z score of -1.71. This is a bad value and indicates that VERU is not financially healthy and even has some risk of bankruptcy.
VERU has a worse Altman-Z score (-1.71) than 83.78% of its industry peers.
A Debt/Equity ratio of 0.19 indicates that VERU is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.19, VERU perfoms like the industry average, outperforming 51.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.71 |
ROIC/WACCN/A
WACC8.9%
2.3 Liquidity
A Current Ratio of 4.72 indicates that VERU has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.72, VERU belongs to the top of the industry, outperforming 86.49% of the companies in the same industry.
A Quick Ratio of 4.22 indicates that VERU has no problem at all paying its short term obligations.
VERU's Quick ratio of 4.22 is amongst the best of the industry. VERU outperforms 86.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.72 | ||
| Quick Ratio | 4.22 |
3. Growth
3.1 Past
VERU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.88%, which is quite impressive.
VERU shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -36.69%.
VERU shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.55% yearly.
EPS 1Y (TTM)76.88%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q85.42%
Revenue 1Y (TTM)-36.69%
Revenue growth 3Y-27.4%
Revenue growth 5Y0.55%
Revenue growth Q2Q-37.25%
3.2 Future
Based on estimates for the next years, VERU will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.19% on average per year.
VERU is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 25.77% yearly.
EPS Next Y72.57%
EPS Next 2Y30.71%
EPS Next 3Y21.03%
EPS Next 5Y12.19%
Revenue Next Year12.01%
Revenue Next 2Y-21.84%
Revenue Next 3Y74.82%
Revenue Next 5Y25.77%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
VERU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VERU. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
VERU's earnings are expected to grow with 21.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.71%
EPS Next 3Y21.03%
5. Dividend
5.1 Amount
No dividends for VERU!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
VERU INC
NASDAQ:VERU (5/15/2024, 10:56:51 AM)
1.485
+0.02 (+1.02%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap217.37M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -49.89% | ||
| ROE | -79.23% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 34.13% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 4.72 | ||
| Quick Ratio | 4.22 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)76.88%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y72.57%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-36.69%
Revenue growth 3Y-27.4%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y